Novo Nordisk CEO Mike Doustdar revealed the company is actively considering mergers and acquisitions to strengthen its position in the competitive weight-loss drug market. He emphasized the company's interest in acquiring or partnering with firms that have developed or are about to launch superior drugs. This strategy aims to fill gaps in Novo Nordisk's portfolio and maintain its market leadership. The move highlights the intensifying competition in the pharmaceutical sector focused on obesity treatments.
Novo Nordisk holds a market cap of $190.93 billion and offers a dividend yield of 4.15%, reflecting its strong position in the health sector. On Pluang, as of Sep 22, 2026 16:11 WIB, the stock trades at USD 39.69 with a slight 1-day decline of 0.33%. Investor interest remains high with 87% of order activity on Pluang being buys, indicating confidence in the company despite the minor dip.
Biotech stocks and leveraged ETFs were the biggest losers in the market, with Cue Biopharma dropping 23.7% despite positive Phase 2 clinical results. Leveraged ETFs tied to AMD, Strategy, and Novo Nordisk also saw sharp declines due to their daily-re...
Novo Nordisk's shares fell over 7% after the company announced long-term targets that failed to reassure investors about competition in the weight-loss drug market. The Danish drugmaker plans to launch multiple blockbuster drugs by 2030 and aims for ...
Novo Nordisk's stock fell 7% following its capital markets day where it outlined a growth plan that aligns with industry peers rather than exceeding them, signaling slower future growth. The company highlighted the upcoming loss of U.S. patent exclus...
Novo, a Danish pharmaceutical company, saw its shares fall up to 7% after announcing plans to launch over five new drugs with blockbuster potential by 2030 and targeting pipeline sales exceeding $23 billion by 2035. The company aims to grow revenue f...
Anthropic has revealed it operates a wet biology lab where its AI models conduct physical experiments, aiming to bridge AI theories with real-world biology. This lab functions like a typical biotech facility, supporting both in-house research and col...
